HONG KONG Oct 4 (Reuters) – Shanghai Fosun Pharmaceutical is set to launch an up to $600 million Hong Kong share offering on Oct 11, IFR reported on Thursday, citing sources with knowledge of the deal. The company is slated to price the share …
Zhengzhou Minzhong Pharmaceutical Co., Ltd.
Rifamycin Sodium|Rifampicin|Rutin